The role involves driving the clinical development of assets targeting TGF-β signaling pathways to provide disease-modifying benefits to patients.
Base: $248,000 - $310,000 USD; Bonus/Equity: Not specified; Benefits: Not specified
Must-have
Nice-to-have
Not specified